Search Results - "Helsen, Christopher W."
-
1
The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity
Published in Nature communications (03-08-2018)“…Engineering T cells with chimeric antigen receptors (CARs) is an effective method for directing T cells to attack tumors, but may cause adverse side effects…”
Get full text
Journal Article -
2
A new perspective on Hsp104-mediated propagation and curing of the yeast prion [PSI+]
Published in Prion (01-07-2012)“…Most prions in yeast form amyloid fibrils that must be severed by the protein disaggregase Hsp104 to be propagated and transmitted efficiently to newly formed…”
Get full text
Journal Article -
3
Insight into Molecular Basis of Curing of [PSI+] Prion by Overexpression of 104-kDa Heat Shock Protein (Hsp104)
Published in The Journal of biological chemistry (02-01-2012)“…Yeast prions are a powerful model for understanding the dynamics of protein aggregation associated with a number of human neurodegenerative disorders. The AAA+…”
Get full text
Journal Article -
4
Primary Structure Elements of Spider Dragline Silks and Their Contribution to Protein Solubility
Published in Biochemistry (Easton) (26-10-2004)“…Spider silk proteins have mainly been investigated with regard to their contribution to mechanical properties of the silk thread. However, little is known…”
Get full text
Journal Article -
5
T-cell engineered with a fully humanized B-cell maturation antigen-specific T-cell antigen coupler receptor effectively target multiple myeloma
Published in Cytotherapy (Oxford, England) (01-05-2023)“…B-cell maturation antigen (BCMA) is a clinically validated target for multiple myeloma. T-cell engineered with chimeric antigen receptors (CARs) directed…”
Get full text
Journal Article -
6
Viral Engineering of Chimeric Antigen Receptor Expression on Murine and Human T Lymphocytes
Published in Methods in molecular biology (Clifton, N.J.) (01-01-2016)“…The adoptive transfer of a bolus of tumor-specific T lymphocytes into cancer patients is a promising therapeutic strategy. In one approach, tumor specificity…”
Get more information
Journal Article -
7
Designed ankyrin repeat proteins are effective targeting elements for chimeric antigen receptors
Published in Journal for immunotherapy of cancer (15-12-2015)“…Adoptive cell transfer of tumor-specific T lymphocytes (T cells) is proving to be an effective strategy for treating established tumors in cancer patients. One…”
Get full text
Journal Article -
8
372 TAC-T cells persist and remain functional during and after repeated tumor exposure in vitro and in vivo
Published in Journal for immunotherapy of cancer (01-11-2023)“…BackgroundT cell antigen coupler (TAC) is a chimeric receptor that redirects T cells (TAC-T) towards surface-expressed tumor antigens to create safe and…”
Get full text
Journal Article -
9
347 Functional characterization of GUCY2C-TAC T cells for the treatment of colorectal cancer using preclinical models
Published in Journal for immunotherapy of cancer (01-11-2023)“…BackgroundThe T cell antigen coupler (TAC) is a novel chimeric receptor that facilitates the redirection of T cells to tumor cells and activates T cells by…”
Get full text
Journal Article -
10
Tumor-targeting domains for chimeric antigen receptor T cells
Published in Immunotherapy (01-01-2017)“…Immunotherapy with chimeric antigen receptor (CAR) T cells has been advancing steadily in clinical trials. Since the ability of engineered T cells to recognize…”
Get full text
Journal Article -
11
400 Preclinical characterization and modelling of allogeneic Vγ9Vδ2 TAC T cells for the treatment of solid tumors
Published in Journal for immunotherapy of cancer (01-11-2023)“…BackgroundThe T cell antigen coupler (TAC) is a novel, proprietary chimeric receptor that facilitates the redirection of T cells to tumor cells and activates T…”
Get full text
Journal Article -
12
The C-terminal Extension of Saccharomyces cerevisiae Hsp104 Plays a Role in Oligomer Assembly
Published in Biochemistry (Easton) (19-02-2008)“…The Saccharomyces cerevisiae protein Hsp104, a member of the Hsp100/Clp AAA+ family of ATPases, and its orthologues in plants (Hsp101) and bacteria (ClpB)…”
Get full text
Journal Article -
13
Abstract 1424: Preclinical development of TAC01-CD19, a CD19 specific T-cell Antigen Coupler (TAC) therapy for the treatment of CD19-positive B cell malignancies
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Background: The T cell antigen coupler (TAC) is a chimeric receptor co-opting the natural TCR receptor signaling complex to target tumor antigens in an…”
Get full text
Journal Article -
14
Abstract 572: Pre-clinical evaluation of Claudin 18.2 TAC T cells for the treatment of gastric cancer
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Background: The T cell antigen coupler (TAC) is a novel, proprietary chimeric receptor that facilitates the re-direction of T cells to tumor cells and…”
Get full text
Journal Article -
15
Abstract 1773: Preclinical characterization of allogeneic Vγ9Vδ2 HER2-TAC T cells for the treatment of HER2-positive solid tumors
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Background: The T cell antigen coupler (TAC) is a novel, proprietary chimeric receptor that facilitates the redirection of T cells to tumor cells and activates…”
Get full text
Journal Article -
16
Abstract 3188: Patient-derived TAC01-HER2 TAC T cells produced in Cocoon® Platform is highly functional in models of solid tumors
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Background: The T cell antigen coupler (TAC) is a novel, proprietary chimeric receptor that facilitates the re-direction of T cells to tumor cells and…”
Get full text
Journal Article -
17
The C-terminal Extension of Saccharomyces cerevisiae Hsp104 Plays a Role in Oligomer Assembly
Published in Biochemistry (Easton) (01-01-2008)“…The Saccharomyces cerevisiae protein Hsp104, a member of the Hsp100/Clp AAA+ family of ATPases, and its orthologues in plants (Hsp101) and bacteria (ClpB)…”
Get full text
Journal Article